Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression
- PMID: 20880178
- DOI: 10.1111/j.1440-1746.2010.06417.x
Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression
Abstract
Background and aim: Circulating miRNAs exist in serum and plasma and they can be used as a potential noninvasive molecular marker for colorectal cancer (CRC) diagnosis. The present study was to test the availability of direct amplification of miRNAs from plasma without RNA extraction, and to evaluate its clinical application value in CRC.
Methods: Plasma miR-21, miR-221 and miR-222 levels were determined in 103 CRC patients and 37 healthy normal controls by quantitative reverse transcription-polymerase chain reaction. Immunohistochemical staining for p53, carcinoembryonic antigen (CEA), estrogen receptor (ER) and progesterone receptor (PR) was carried out in the same CRC patient cohort. The correlation between miR-221 levels and protein levels of p53, CEA, ER and PR, clinicopathological features or overall survival was analyzed.
Results: A standard curve shows a good linearity between the log of sample input and C(T) values over three orders of magnitude of plasma miR-21, miR-221 and miR-222. ROC curve analysis reveals that the plasma levels of miR-221 is a potential biomarker for differentiating CRC patients from controls. Kaplan-Meier curve assessment shows that the elevated plasma miR-221 level is a significant prognostic factor for poor overall survival in CRC patients. The immunohistochemistry analysis demonstrates a significant correlation between plasma miR-221 level and p53 expression.
Conclusions: The direct amplification of plasma miR-221 can be used as a potential noninvasive molecular marker for diagnosis and prognosis of CRC and is correlated with p53 expression.
© 2010 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.
Similar articles
-
Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.Gut. 2009 Oct;58(10):1375-81. doi: 10.1136/gut.2008.167817. Epub 2009 Feb 6. Gut. 2009. PMID: 19201770
-
Prognostic implications of serum microRNA-21 in colorectal cancer.J Surg Oncol. 2013 Nov;108(6):369-73. doi: 10.1002/jso.23415. Epub 2013 Aug 23. J Surg Oncol. 2013. PMID: 23970420
-
Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.J Gastroenterol Hepatol. 2006 Oct;21(10):1596-603. doi: 10.1111/j.1440-1746.2006.04228.x. J Gastroenterol Hepatol. 2006. PMID: 16928223
-
Diagnostic and prognostic significance of serum microRNAs in colorectal cancer.J Surg Oncol. 2013 Feb;107(2):217-20. doi: 10.1002/jso.23245. Epub 2012 Aug 17. J Surg Oncol. 2013. PMID: 22903548 Review.
-
MicroRNA signatures: novel biomarker for colorectal cancer?Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1272-86. doi: 10.1158/1055-9965.EPI-11-0035. Epub 2011 May 6. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21551242 Review.
Cited by
-
Cell-free Circulating miRNA Biomarkers in Cancer.J Cancer. 2012;3:432-48. doi: 10.7150/jca.4919. Epub 2012 Oct 13. J Cancer. 2012. PMID: 23074383 Free PMC article.
-
MicroRNA manipulation in colorectal cancer cells: from laboratory to clinical application.J Transl Med. 2012 Jun 20;10:128. doi: 10.1186/1479-5876-10-128. J Transl Med. 2012. PMID: 22716183 Free PMC article. Review.
-
Use of Personalized Biomarkers in Metastatic Colorectal Cancer and the Impact of AI.Cancers (Basel). 2022 Oct 3;14(19):4834. doi: 10.3390/cancers14194834. Cancers (Basel). 2022. PMID: 36230757 Free PMC article. Review.
-
Circulating cell-free microRNAs as biomarkers for colorectal cancer.Surg Today. 2016 Jan;46(1):13-24. doi: 10.1007/s00595-015-1138-y. Epub 2015 Feb 25. Surg Today. 2016. PMID: 25712224
-
Current Update of Laboratory Molecular Diagnostics Advancement in Management of Colorectal Cancer (CRC).Diagnostics (Basel). 2019 Dec 23;10(1):9. doi: 10.3390/diagnostics10010009. Diagnostics (Basel). 2019. PMID: 31877940 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous